SSA
AHPI

Schonfeld Strategic Advisors’s Allied Healthcare Products AHPI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AHPI Stock Details AHPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,300
Closed -$15.9K – 2974
2022
Q4 		$15.9K Sell
17,300
-400
-2% -$471 ﹤0.01% 2337
2022
Q3 		$24K Sell
17,700
-100
-0.6% -$184 ﹤0.01% 2705
2022
Q2 		$29K Buy
17,800
+200
+1% +$454 ﹤0.01% 2277
2022
Q1 		$57K Sell
17,600
-100
-0.6% -$353 ﹤0.01% 2326
2021
Q4 		$103K Buy
17,700
+700
+4% +$4.01K ﹤0.01% 1878
2021
Q3 		$117K Buy
+17,000
New +$132K ﹤0.01% 1898

Schonfeld Strategic Advisors's AHPI Position: Q1 2023 in Review

Schonfeld Strategic Advisors sold out of Allied Healthcare Products (AHPI) in Q1 2023, closing a stake of 17,300 shares — an estimated $15.9K sold.

Schonfeld Strategic Advisors first reported a position in AHPI in Q3 2021 and held it in 6 quarters. The position peaked at $117K in Q3 2021. 1 fund tracked by Wall St. Rank holds AHPI as of Q1 2023.

  • Schonfeld Strategic Advisors reported no remaining Allied Healthcare Products position as of Q1 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 17,300 Allied Healthcare Products shares in Q1 2023, an estimated $15.9K.
  • Schonfeld Strategic Advisors first reported a position in Allied Healthcare Products in Q3 2021 and held it in 6 quarters.
  • Schonfeld Strategic Advisors's Allied Healthcare Products position peaked at $117K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Allied Healthcare Products as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.